ExpressCells
Nearby engineering companies
Market Street/3rd Floor
Market Street
ExpressCells uses genetic engineering to create custom cell lines for biological research
ExpressCells' founder, Oscar Perez-Leal, has published a new case study of our gene-edited cell lines in Biomolecules. Check it out: https://bit.ly/ExpressCells-Biomolecules-Article
ExpressCells Co-founder Publishes New Data Derived from Cells Gene-Edited with FAST-HDR | ExpressCells The laboratory of Oscar Perez Leal, MD, co-founder of ExpressCells and Assistant Professor at Temple University, published data derived from cells created with FAST-HDR gene editing system. This illustrates a practical use of cells available from ExpressCells. PHILADELPHIA - Feb. 13, 2023 - PRLog --...
Wishing our clients, colleagues and friends a wonderful holiday season! | ExpressCells Wishing our clients, colleagues and friends a wonderful holiday season! — ExpressCells. Cell line gene editing; Cell line development; CRISPR DNA editing, CRISPR gene editing technology; Knock-in; Cell line service. by ExpressCells | Dec 23, 2022 | Company news Better Knock-ins, Better Cell Lines,...
Did you miss the ExpressCells webinar on gene-editing? No problem! Watch it on-demand at xpresscells.com.
Did you miss the ExpressCells webinar on gene-editing? No problem! Watch it on-demand at xpresscells.com. | ExpressCells Creating Better Gene-Edited Cell Lines with the FAST-HDR System What You’ll Learn: Understand the current challenges in creating custom gene-edited cell lines Know the technology underlying the FAST-HDR gene-editing system, including its use with CRISPR Be able to describe the advantages of the FA...
Did you miss the ExpressCells webinar on gene-editing last week? No problem! Watch it on-demand at
Creating Better Gene-Edited Cell Lines with the FAST-HDR System Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. Since the 1980s, genetic manipulation has allowed researchers to tailor cell lines to the experiment or production purpose. Ov...
Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. This webinar will discuss the basis of the FAST-HDR technology and illustrate several uses. The first part is a presentation by Oscar Perez-Leal, MD, the inventor of the technology. Oscar will […]
Be sure to join ExpressCells at the upcoming live webinar event, Creating Better Gene-Edited Cell Lines, Wednesday, October 26, 2022, 11:00 AM ET | ExpressCells Cell lines are the core of biological research. Scientists need cell lines for drug development, basic biology research, safety testing, and biologic therapeutic production. This webinar will discuss the basis of the FAST-HDR technology and illustrate several uses. The first part is a presentation b...
No scientist wants to wait to start an experiment. ExpressCells gets it–we were founded by scientists. That’s why we developed the patented FAST-HDR gene-editing system. Want a single knock-in? In many cases, we can send you a cell pool in about 60 days. Give us a little more time and we can deliver a clonal selection and/or a cell with multiple knock-ins. We also do knock-outs and point mutations. Now you […]
No scientist wants to wait to start an experiment. ExpressCells gets it–we were founded by scientists. | ExpressCells That’s why we developed the patented FAST-HDR gene-editing system. Want a single knock-in? In many cases, we can send you a cell pool in about 60 days. Give us a little more time and we can deliver a clonal selection and/or a cell with multiple knock-ins. We also do knock-outs and point mutations....
Shamim Naghdi, Scientific Director at ExpressCells, shares her story in CIC’s latest campaign. Learn More About CIC
How good is the ExpressCells team? So good that CIC is featuring Shamim Naghdi PhD, our amazing Scientific Director, in their new ad campaign! | ExpressCells Shamim Naghdi, Scientific Director at ExpressCells, shares her story in CIC's latest campaign. See Story Learn More About CIC Visit CIC
We're presenting to Investors at CONNECTpreneur next week. Hope you can join us! https://www.facebook.com/Connectpreneur/posts/pfbid0HHXTVPxsncDy5ZyYv6hyUEwaci5Ap7cyiBmbHLFPZP6F7BTfayEotVHUroAbofdal
Virtual Rocket Pitch + Power Networking by CONNECTpreneur Investor Network CONNECTpreneur's Virtual Rocket Pitch - The world's largest investor pitch events. Come learn, connect with others, and be inspired
Join the ExpressCells team! We’re looking for a Senior Genetic Engineering Scientist
Join the ExpressCells team! We’re looking for a Senior Genetic Engineering Scientist #opportunity #geneediting | ExpressCells Join our Team!
We’re a #4 seed 2022 PHL INNO Madness, but want to show we can win it all. Vote for ExpressCells in round one of the tournament! Voting ends at 11:59pm on March 7th
This is your chance to show your support for ExpressCells. We are one of 16 companies in the 2022 PHL INNO Madness Bracket. | ExpressCells We're a #4 seed, but want to show we can win it all. Vote for ExpressCells in round one of the tournament! Voting ends at 11:59pm on March 7th VOTE NOW
ExpressCells is hiring! Know a great genetic engineering scientist? Please share this opening with them.
ExpressCells congratulates our Co-Founder, Oscar Perez-Leal and his colleagues for the first publication featuring ExpressCells' FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at https://xpresscells.com/
ExpressCells congratulates our Co-Founder, Oscar Perez Leal and his colleagues for the first publication featuring ExpressCells’ FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at xpresscells.com. |... "We believe the FAST-HDR system is a versatile methodology for developing endogenous tagging with CRISPR according to the needs of the researcher, as it works on any cell line, facilitates multiplexing, and allows the use of any protein tag." Download Full Press Release Read the Article from The CRI...
ExpressCells, Inc., and Funakoshi Co., Ltd., a leading Japanese distributor of scientific products, announced today that the companies have entered into a strategic partnership where Funakoshi will distribute ExpressCells’ products in Japan. “We are honored that Funakoshi, a highly-respected company with a long history of extending the frontiers in life science, will distribute our catalog […]
ExpressCells and Funakoshi Establish Japanese Distribution Agreement. Partnership will Introduce ExpressCells’ Genetically-Edited Cell Lines to Japan | ExpressCells ExpressCells, Inc., and Funakoshi Co., Ltd., a leading Japanese distributor of scientific products, announced today that the companies have entered into a strategic partnership where Funakoshi will distribute ExpressCells' products in Japan. "We are honored that Funakoshi, a highly-respected company...
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
3675 Market Street , Suite 200
Philadelphia, PA
19104
3675 Market Street Suite 200
Philadelphia, 19104
We are developing next gen solutions for animal and human reproductive health.
Philadelphia
Commercial Co-Working for Life Science Start-Ups & Virtual Biotech Companies. Qualified Tenant Typ
Philadelphia, 19146
Gnosko accelerates scientific progress and delivers value by ensuring the best products, service, a
230 S. Broad Street, Suite 1201
Philadelphia, 19102
ViaClean Technologies focuses on advanced antimicrobial surface protection solutions
401 N Broad Street Suite 222
Philadelphia, 19108
Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance.
Philadelphia, 19100
Cell Eleven is a DIY biotech tool company focusing on modularity, cost, and accessibility.
3675 Market Street
Philadelphia, 19104
Century Therapeutics is developing novel allogeneic living drugs for oncology that overcome the limi
Philadelphia
Protalex, Inc. (OTCQB: PRTX) is focused on the development of a class of drugs for treating a wide a